The Scientific Liaison Coalition (SLC) will hold its next webinar series beginning on Tuesday, May 17, 2016. An SLC Work Group comprised of Mary Jeanne Kallman, Safety Pharmacology Society; Donna Mendrick, Society of Toxicology; and Arun Pandiri, Society of Toxicologic Pathology, has developed a Use of Animal Models of Disease for Toxicity Prediction Webinar Series. This series will provide pharmaceutical industry and regulatory perspectives on this topic. The dates and speakers are listed below. All webinars will be held from 11:00 am–12:30 pm ET USA and registration for the first webinar now is open.
- May 17: Diann Blanset, Boehringer Ingelheim
- May 31: Sruthi King, US Food and Drug Administration
- June 21: Sherry Morgan, AbbVie, Inc.
On May 17, Dr. Blanset will present The Use of Animal Models of Disease in Safety Assessments. The aim of this webinar is to review the use of animal models of disease in the evaluation of exaggerated pharmacology and toxicity to improve the relevance and extrapolation of the assessments to the intended disease population. The basic principles of the use of animal models of disease will be reviewed as well as the advantages and disadvantages of these models. In addition, specific examples of the use of these models in safety assessments will be presented.
Dr. Blanset has more than 25 years of experience in the pharmaceutical industry and she is currently a Distinguished Research Fellow at Boehringer Ingelheim, leading nonclinical safety assessment programs. She is an active member of SOT and the American College of Toxicology, having served as Secretary/Treasurer for the Mid-Atlantic Chapter and the Biotechnology Specialty Section of SOT. She also has been a member of BIO’s BioSafe Leadership Committee since 2008.
The mission of the SLC is “improving the ability of societies to partner with other domestic and international organizations that have objectives consistent with the goal of increasing the impact of the science of toxicology to improve public health" by:
- Strengthening partnerships among scientific, biomedical, and other health-based organizations to increase awareness of the impact of toxicology, diseases, and related subjects on human health.
- Functioning as a means to enhance cooperation among societies as equals with the goal of accomplishing tasks benefiting human health and disease prevention through joint and shared activities.
This live webinar is open only to members of the partnering societies of the SLC, which are listed on the SLC website and you must register to attend. For more information on the SLC, please contact Marcia Lawson.